U.S. markets closed

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.00+0.05 (+0.72%)
At close: 03:01PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close6.95
Bid2.68 x 3100
Ask7.26 x 1400
Day's Range7.00 - 7.00
52 Week Range1.75 - 11.00
Avg. Volume19,031
Market Cap329.778M
Beta (5Y Monthly)1.29
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for NBTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nanobiotix S.A.
    Daily – Vickers Top Buyers & Sellers for 12/22/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more

    Baillie Gifford Bolsters Stake in Nanobiotix SA

    Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently increased its investment in Nanobiotix SA, a company at the forefront of nanotechnology in cancer treatment. This transaction was executed at a trade price of $5.81 per share, reflecting a 48.18% change in the firm's holdings and a 6.21% ownership in Nanobiotix SA. Despite the significant addition, the trade had a negligible impact on Baillie Gifford (Trades, Portfolio)'s portfolio, with the position accounting for just 0.02% of its total investments.

  • Benzinga

    Nanobiotix Stock Triples In Trading Session: What's Going On With Stock On Friday

    Nanobiotix (NASDAQ: NBTX) shares gained more than 200% on Friday trading after it entered into final contract negotiations with a major global pharmaceutical company. In its Q4 earnings release, Nanobiotix raised going concerns. The company noted net losses of €57.0 million in 2022 and a net decrease in cash and cash equivalents of €42.5 million in 2022. Nanobiotix stock is gaining on heavy volume, with a session volume of 30.262 million shares traded. The company agreed to a non-binding term sh